These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 21240149

  • 1. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z, Gao K, Kemp DE, Chan PK, Serrano MB, Conroy C, Fang Y, Ganocy SJ, Findling RL, Calabrese JR.
    Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
    [Abstract] [Full Text] [Related]

  • 2. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.
    Kemp DE, Gao K, Fein EB, Chan PK, Conroy C, Obral S, Ganocy SJ, Calabrese JR.
    Bipolar Disord; 2012 Nov; 14(7):780-9. PubMed ID: 23107222
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
    Redmond JR, Jamison KL, Bowden CL.
    CNS Spectr; 2006 Dec; 11(12):915-8. PubMed ID: 17146405
    [Abstract] [Full Text] [Related]

  • 4. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 Dec; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 6. Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies.
    Gao K, Kemp DE, Wang Z, Ganocy SJ, Conroy C, Serrano MB, Sajatovic M, Findling RL, Calabrese JR.
    Psychopharmacol Bull; 2010 Nov; 43(1):23-38. PubMed ID: 20581798
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA, LamLit Study Group.
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [Abstract] [Full Text] [Related]

  • 8. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.
    Muzina DJ, Gao K, Kemp DE, Khalife S, Ganocy SJ, Chan PK, Serrano MB, Conroy CM, Calabrese JR.
    J Clin Psychiatry; 2011 Jun; 72(6):813-9. PubMed ID: 20816041
    [Abstract] [Full Text] [Related]

  • 12. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN, Vieta E, Young AH, Möller HJ, Paulsson B, Vågerö M.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B.
    J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
    [Abstract] [Full Text] [Related]

  • 15. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842
    [Abstract] [Full Text] [Related]

  • 16. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG, Chou JC, Keck PE, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ.
    Arch Gen Psychiatry; 2000 May 01; 57(5):481-9. PubMed ID: 10807488
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I (Trial 001) Investigators.
    J Clin Psychiatry; 2010 Feb 01; 71(2):150-62. PubMed ID: 20122369
    [Abstract] [Full Text] [Related]

  • 18. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A, Cucchiaro J, Silva R, Kroger H, Sarma K, Xu J, Calabrese JR.
    Am J Psychiatry; 2014 Feb 01; 171(2):169-77. PubMed ID: 24170221
    [Abstract] [Full Text] [Related]

  • 19. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T, Kroger H, Pikalov A, Loebel A.
    J Psychiatr Res; 2016 Jul 01; 78():86-93. PubMed ID: 27089521
    [Abstract] [Full Text] [Related]

  • 20. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
    Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, Findling RL, Calabrese JR.
    J Clin Psychiatry; 2009 Jan 01; 70(1):113-21. PubMed ID: 19192457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.